DLB vs IMAX
DLB: Dolby Laboratories is a global leader in audio and imaging technology innovation, monetizing its intellectual property through licensing agreements with the consumer electronics, broadcast, and entertainment industries. IMAX: IMAX operates the world's largest premium cinema network, capturing a premium from blockbuster films and iconic events through proprietary immersive theater technology and format enhancement services.
Side-by-side fundamentals
| Metric | DLB | IMAX | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $49.13 | $39.30 | |
| Market cap as of 2026-07-23 | $4.7B | $2.2B | |
| P/E as of 2026-07-23 | 19.33 | 58.62 | DLB lower |
| PEG as of 2026-07-23 | n/a | 1.33 | |
| Net margin as of 2026-07-23 | +17.9% | +9.1% | DLB higher |
| Gross margin as of 2026-07-23 | +87.4% | +59.0% | DLB higher |
| Operating margin as of 2026-07-23 | +18.5% | +19.1% | IMAX higher |
| ROE as of 2026-07-23 | +9.3% | +10.9% | IMAX higher |
| ROA as of 2026-07-23 | +7.6% | +4.2% | DLB higher |
| Debt / equity as of 2026-07-23 | 0.00 | 0.87 | DLB lower |
| Revenue growth (YoY) as of 2026-07-23 | +3.4% | +12.6% | IMAX higher |
| Revenue CAGR (3y) SEC XBRL | +2.5% | +10.9% | IMAX higher |
| Dividend yield as of 2026-07-23 | +2.9% | n/a | |
| Dividend streak (yrs) SEC XBRL | 5 | n/a | |
| Beta as of 2026-07-23 | 0.82 | 0.43 | |
| 1-year return as of 2026-07-22 close | -35.9% | +39.2% | IMAX higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.